具有高度细胞毒性的加密衍生物,在D单元中进行合修改
Cedric Dessin1, Thomas Schachtsiek1, Jona Voss1
1Organic and Bioorganic Chemistry, Department of Chemistry, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany.
Angewandte Chemie (International ed. in English)
|September 26, 2024
概括
为向癌症治疗合成了具有强烈的皮科莫尔细胞毒性的新型密码素类似物. 在D单元的修改使结合成为可能,增强了对抗多药耐药瘤的疗效.
科学领域:
- 药用化学 医学化学
- 自然产品的合成自然产品的合成
- 癌症治疗方法 癌症治疗方法
背景情况:
- 细胞毒性有效载荷对于针对性癌症治疗中的抗体-药物结合物至关重要.
- 密码素是高度细胞毒性环,但对结合的功能化具有挑战性.
- 鉴定出D单元 (酸) 的修改是结合手柄的潜在部位.
研究的目的:
- 开发一种可扩展的合成路径,用于可结合的密码生物.
- 为了合成具有多种功能组的新型加密素类似物,用于结合.
- 评估新类型的细胞毒性和疗效,特别是针对多药耐药癌细胞.
主要方法:
- 开发一种多功能和高效的合成路径,用于修改的加密生物.
- 合成了一系列加密素类似物库,具有各种结合 (氨基,氧,碳氧,含硫组).
- 细胞毒性测定,包括对多药耐药细胞系的评估.
- 管结合的密码素的X射线晶体学和定量结构-活性关系 (QSAR) 分析.
主要成果:
- 成功合成了新型的,可结合的加密素类似物,在D单元中进行了修改.
- 几种衍生品表现出极高的细胞毒性 (低皮科摩尔范围).
- 脂友性修饰,如化氨基基团,增强了对抗多药耐药瘤的效能和有效性.
- 建立了结构-活动关系,并证实了D单元修改的适用性.
结论:
- 开发的合成策略使得能够制造出高强度,可结合的加密生物.
- 修改后的密码素显示为向癌症治疗的有效载荷,包括对抗耐药癌症.
- 单元D的修改耐受性很好,对于开发有效的药物合物至关重要.
更多相关视频
13:06Solubilization and Bio-conjugation of Quantum Dots and Bacterial Toxicity Assays by Growth Curve and Plate Count
Published on: July 11, 2012
14.3K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
相关概念视频
Phase II Conjugation Reactions: Overview
172
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
172
Phase II Reactions: Miscellaneous Conjugation Reactions
48
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
48
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K
